Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07TDM
|
||||
| Former ID |
DNC014353
|
||||
| Drug Name |
PHASEOLIN
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C20H18O4
|
||||
| Canonical SMILES |
CC1(C=CC2=C(O1)C=CC3=C2OC4C3COC5=C4C=CC(=C5)O)C
|
||||
| InChI |
1S/C20H18O4/c1-20(2)8-7-14-16(24-20)6-5-12-15-10-22-17-9-11(21)3-4-13(17)19(15)23-18(12)14/h3-9,15,19,21H,10H2,1-2H3/t15-,19-/m0/s1
|
||||
| InChIKey |
LWTDZKXXJRRKDG-KXBFYZLASA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||